Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 9 of 19 found articles
 
 
  Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial
 
 
Title: Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial
Author: Landovitz, Raphael J
Hanscom, Brett S
Clement, Meredith E
Tran, Ha V
Kallas, Esper G
Magnus, Manya
Sued, Omar
Sanchez, Jorge
Scott, Hyman
Eron, Joe J
del Rio, Carlos
Fields, Sheldon D
Marzinke, Mark A
Eshleman, Susan H
Donnell, Deborah
Spinelli, Matthew A
Kofron, Ryan M
Berman, Richard
Piwowar-Manning, Estelle M
Richardson, Paul A
Sullivan, Philip A
Lucas, Jonathan P
Anderson, Peter L
Hendrix, Craig W
Adeyeye, Adeola
Rooney, James F
Rinehart, Alex R
Cohen, Myron S
McCauley, Marybeth
Grinsztejn, Beatriz
Appeared in: The Lancet. HIV
Paging: Volume 10 () nr. 12 pages e767-e778
Year: 2023
Contents:
Publisher: Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 9 of 19 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands